Patents/Assignees

BIO-PATH HOLDINGS, Inc.

4 patents in portfolio

US12319911utility2025
P-ethoxy Nucleic Acids for STAT3 Inhibition
0 cites
US12234457utility2025
P-ethoxy Nucleic Acids for BCL2 Inhibition
0 cites
US12097214utility2024
P-ethoxy Nucleic Acids for Liposomal Formulation
0 cites
US12012601utility2024
Combination Therapy with Liposomal Antisense Oligonucleotides
0 cites